European Journal of Chemistry

Urease inhibition and anticancer activity of novel polyfunctional 5,6-dihydropyridine derivatives and their structure-activity relationship

Main Article Content

Abdul Hameed
Ayaz Anwar
Khalid Mohammed Khan
Rizwana Malik
Fernaz Shahab
Sadia Siddiq
Fatima Zahra Basha
Muhammad Iqbal Choudhary


A novel series of tricyano substituted polyfunctional 5,6-dihydropyridine 8a-n bearing functionalized aromatic rings at C-4 and C-6 position have been prepared from (α-methylbenzylidene) malononitriles in good to excellent yields (52-98%) in solvent free conditions. All the synthesized compounds (8a-n) were evaluated for their in vitro urease inhibition and anticancer activity against prostate cancer (PC3) and Hela cell lines. Compound 8k (4,6-bis(4-methoxyphenyl)-5,6-dihydropyridin) showed slightly better urease inhibitory potential (IC50 = 20.47 µM) as compared to standard thiourea (IC50 = 21 µM). Whilst in the case of anticancer studies the compound 8a 2-(4,6-bis(4-bromophenyl)-6-methyl-5,6-dihydropyridin found to be most active (IC50 = 4.40 and 8.80 µM) among the series when compared with standard doxorubicin 4 (IC50 = 0.91 and 3.1 µM) in both cell lines respectively. A structure-activity relationship of this series has been established on the basis of electronic effects and position of different substituents (H, Br, Cl, I, F, Me, OMe, OH, and NO2) present on the C-4 and C-6 phenyl rings. The anticancer activity evaluation of these pyridine derivatives envisage that the compound 8a could be putatively linked with doxorubicin IV to developed new anticancer prodrugs for multidrug resistant (MDR) cancer cells. All the synthesized compounds were characterized by spectroscopic techniques.


icon graph This Abstract was viewed 2460 times | icon graph Article PDF downloaded 891 times

How to Cite
Hameed, A.; Anwar, A.; Khan, K. M.; Malik, R.; Shahab, F.; Siddiq, S.; Basha, F. Z.; Choudhary, M. I. Urease Inhibition and Anticancer Activity of Novel Polyfunctional 5,6-Dihydropyridine Derivatives and Their Structure-Activity Relationship. Eur. J. Chem. 2013, 4, 49-52.

Article Details

Crossref - Scopus - Google - European PMC

[1]. Hargreaves, S. L.; Pilkington, B. L.; Russell, S. E.; Worthington, P. A. Tetrahedron Lett. 2000, 41, 1653-1656.

[2]. Malicorne, G.; Bompart, J.; Giral, L.; Despaux, E. Eur. J. Med. Chem. 1991, 26, 3-11.

[3]. Szoko, E.; Tabi, T. J. Pharm, Biomed. Anal. 2010, 53, 1180-1192.

[4]. Hameed, A.; Anwar, A.; Yousaf, S.; Khan, K. M.; Basha, F. Z. Eur. J. Chem. 2012, 3, 179-185.

[5]. Burne, R. A.; Chen, Y.-Y. M. Microbes and Infect. 2000, 2, 533-542.

[6]. Mobley, H. L. T.; Hausinger, R. P. Microbiol. Rev. 1989, 53, 85-100.
PMid:2651866 PMCid:372718

[7]. Menna, P.; Gonzalez Paz, O.; Chello, M.; Covino, E.; Salvatorelli, E.; Minotti, G. Expet. Opin. Drug Saf. 2012, 11, S21-S36.

[8]. Koch, T.; Barthel, B.; Kalet, B.; Rudnicki, D.; Post, G.; Burkhart, D.: Anthracycline-Formaldehyde Conjugates and Their Targeted Prodrugs Anthracycline Chemistry and Biology II. Krohn, K., Ed.; Springer Berlin/Heidelberg, 2008, 283, 141-170.

[9]. Talelli, M.; Morita, K.; Rijcken, C. J.; Aben, R. W.; Lammers, T.; Scheeren, H. W.; Van Nostrum, C. F.; Storm, G.; Hennink, W. E. Bioconjug. Chem. 2011, 22, 2519-2530.

[10]. Volm, M.; Mattern, J.; Samsel, B. Br. J. Cancer 1991, 64, 700-704.
PMid:1680367 PMCid:1977695

[11]. Toyota, K.; Shinkai, H.; Eto, H.; Kamimura, A.; Eguchi, C.; Ohsumi, K.; Tsuruo, T. U.S. Patent Application 5216172, 1993. 01.07.

[12]. Abadi, A. H.; Ibrahim, T. M.; Abouzid, K. M.; Lehmann, J.; Tinsley, H. N.; Gary, B. D.; Piazza, G. A. Bioorg. Med. Chem. 2009, 17, 5974-5982.

[13]. Weatherburn, M. W. Anal. Chem. 1967, 39, 971-974.

[14]. Mosmann, T. J. Immunol. Methods 1983, 65, 55-63.

Most read articles by the same author(s)

Most read articles by the same author(s)


Dimensions - Altmetric - scite_ - PlumX

Downloads and views


Download data is not yet available.


Metrics Loading ...
License Terms

License Terms


Copyright © 2024 by Authors. This work is published and licensed by Atlanta Publishing House LLC, Atlanta, GA, USA. The full terms of this license are available at and incorporate the Creative Commons Attribution-Non Commercial (CC BY NC) (International, v4.0) License ( By accessing the work, you hereby accept the Terms. This is an open access article distributed under the terms and conditions of the CC BY NC License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited without any further permission from Atlanta Publishing House LLC (European Journal of Chemistry). No use, distribution, or reproduction is permitted which does not comply with these terms. Permissions for commercial use of this work beyond the scope of the License ( are administered by Atlanta Publishing House LLC (European Journal of Chemistry).